MedTrace Logo

Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin

NCT04431141 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-11-15

No results posted yet for this study

Summary

This study is to evaluate pharmacokinetic drug interaction between teneligliptin and empagliflozin in healthy adults.

Conditions

Interventions

DRUG

Teneligliptin

Teneligliptin alone

DRUG

Empagliflozin

Empagliflozin alone

DRUG

Teneligliptin and Empagliflozin

Teneligliptin and empagliflozin

Sponsors & Collaborators

  • Handok Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2020-11-16
Completion
2021-01-25

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04431141 on ClinicalTrials.gov